ALKS stock · RUN stock

ALKS vs RUN

Alkermes Plc (ALKS) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.

Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.

Sunrun Inc (RUN) is a solar company listed on NASDAQ.

Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.

Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.

ALKS currently screens at market cap $4.78B and trailing P/E 13.8. RUN currently screens at market cap $3.05B and trailing P/E 6.0.

Not investment advice. Open the ALKS and RUN stock pages for the full models.

Not investment advice.

Popular Stock Comparisons